Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue

Terminated

• Conditions: Breast Neoplasms

• Registration Number: NCT00184210
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer. The tissue specimen are analyzed by MR spectroscopy. After MR, the intact tissue specimen can be analyzed by other methods, such as histopathology.

The MR spectral profiles are compared to clinical findings such as the patients diagnosis, lymph node status and tumor size.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-01
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-16
• Primary Completion: 2020-12
• Study Completion: 2020-12
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-18
• Last Update Posted: 2021-03-22

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 1000

Inclusion Criteria

• Palpable breast cancer lesion

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
MRimage of breast cancer tissue	0 hour

Trial Locations

Locations (1)

Norwegian University of Technology and Science; 🇳🇴 Trondheim, Norway